Vera Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | |
| – | -50.7% | -29.9% | -580.7% | – | – | -78.4% | |
| – | – | – | – | +120.1% | -216.5% | – | |
| – | +502.4% | -48.8% | +206.9% | +13.4% | +61.3% | +70.6% | |
| – | -8.4% | +195.1% | +83.8% | +8.6% | +72.4% | +144.4% | |
| – | +308.6% | -28.0% | +164.2% | +12.2% | +63.9% | +88.7% | |
| – | – | – | – | – | – | – | |
| – | +225.5% | -88.0% | +4,860.0% | +281.7% | +101.4% | -1.2% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.